116 related articles for article (PubMed ID: 18800014)
1. c-Jun N-terminal kinase mediates lactacystin-induced dopamine neuron degeneration.
Li X; Du Y; Fan X; Yang D; Luo G; Le W
J Neuropathol Exp Neurol; 2008 Oct; 67(10):933-44. PubMed ID: 18800014
[TBL] [Abstract][Full Text] [Related]
2. Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo.
Du Y; Li X; Yang D; Zhang X; Chen S; Huang K; Le W
Exp Biol Med (Maywood); 2008 Jul; 233(7):881-90. PubMed ID: 18445767
[TBL] [Abstract][Full Text] [Related]
3. Proteasome inhibition modeling nigral neuron degeneration in Parkinson's disease.
Xie W; Li X; Li C; Zhu W; Jankovic J; Le W
J Neurochem; 2010 Oct; 115(1):188-99. PubMed ID: 20649845
[TBL] [Abstract][Full Text] [Related]
4. Retrograde dopaminergic neuron degeneration following intrastriatal proteasome inhibition.
Miwa H; Kubo T; Suzuki A; Nishi K; Kondo T
Neurosci Lett; 2005 May 20-27; 380(1-2):93-8. PubMed ID: 15854758
[TBL] [Abstract][Full Text] [Related]
5. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
6. Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway.
Yu S; Zheng W; Xin N; Chi ZH; Wang NQ; Nie YX; Feng WY; Wang ZY
Rejuvenation Res; 2010 Feb; 13(1):55-64. PubMed ID: 20230279
[TBL] [Abstract][Full Text] [Related]
7. Regulation of axotomy-induced dopaminergic neuron death and c-Jun phosphorylation by targeted inhibition of cdc42 or mixed lineage kinase.
Crocker SJ; Hayley SP; Smith PD; Mount MP; Lamba WR; Callaghan SM; Slack RS; Park DS
J Neurochem; 2006 Jan; 96(2):489-99. PubMed ID: 16336220
[TBL] [Abstract][Full Text] [Related]
8. The pattern of neuronal loss and survival may reflect differential expression of proteasome activators in Parkinson's disease.
McNaught KS; Jnobaptiste R; Jackson T; Jengelley TA
Synapse; 2010 Mar; 64(3):241-50. PubMed ID: 19924695
[TBL] [Abstract][Full Text] [Related]
9. The herbicide paraquat induces dopaminergic nigral apoptosis through sustained activation of the JNK pathway.
Peng J; Mao XO; Stevenson FF; Hsu M; Andersen JK
J Biol Chem; 2004 Jul; 279(31):32626-32. PubMed ID: 15155744
[TBL] [Abstract][Full Text] [Related]
10. Prevention and restoration of lactacystin-induced nigrostriatal dopamine neuron degeneration by novel brain-permeable iron chelators.
Zhu W; Xie W; Pan T; Xu P; Fridkin M; Zheng H; Jankovic J; Youdim MB; Le W
FASEB J; 2007 Dec; 21(14):3835-44. PubMed ID: 17690154
[TBL] [Abstract][Full Text] [Related]
11. A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats.
Pain S; Barrier L; Deguil J; Milin S; Piriou A; Fauconneau B; Page G
Toxicology; 2008 Jan; 243(1-2):124-37. PubMed ID: 18037221
[TBL] [Abstract][Full Text] [Related]
12. Nigral injection of a proteasomal inhibitor, lactacystin, induces widespread glial cell activation and shows various phenotypes of Parkinson's disease in young and adult mouse.
Savolainen MH; Albert K; Airavaara M; Myöhänen TT
Exp Brain Res; 2017 Jul; 235(7):2189-2202. PubMed ID: 28439627
[TBL] [Abstract][Full Text] [Related]
13. Proteasome inhibitor MG-132 induces dopaminergic degeneration in cell culture and animal models.
Sun F; Anantharam V; Zhang D; Latchoumycandane C; Kanthasamy A; Kanthasamy AG
Neurotoxicology; 2006 Sep; 27(5):807-15. PubMed ID: 16870259
[TBL] [Abstract][Full Text] [Related]
14. Protective role of heat shock and heat shock protein 70 in lactacystin-induced cell death both in the rat substantia nigra and PC12 cells.
Ahn TB; Jeon BS
Brain Res; 2006 May; 1087(1):159-67. PubMed ID: 16626658
[TBL] [Abstract][Full Text] [Related]
15. [Sleep changes during degeneration of neurons in the substantia nigra induced by inhibitor of proteasomes lactacystin in rats].
Pastukhov IuF; Chesnokova AIu; Iakimchuk AA; Ekimova IV; Romanova IV; Khudik KA
Ross Fiziol Zh Im I M Sechenova; 2010 Dec; 96(12):1190-202. PubMed ID: 21473106
[TBL] [Abstract][Full Text] [Related]
16. Genetic iron chelation protects against proteasome inhibition-induced dopamine neuron degeneration.
Zhu W; Li X; Xie W; Luo F; Kaur D; Andersen JK; Jankovic J; Le W
Neurobiol Dis; 2010 Feb; 37(2):307-13. PubMed ID: 19818853
[TBL] [Abstract][Full Text] [Related]
17. Proteasome inhibition causes nigral degeneration with inclusion bodies in rats.
McNaught KS; Björklund LM; Belizaire R; Isacson O; Jenner P; Olanow CW
Neuroreport; 2002 Aug; 13(11):1437-41. PubMed ID: 12167769
[TBL] [Abstract][Full Text] [Related]
18. Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate.
Harrison IF; Anis HK; Dexter DT
Neurosci Lett; 2016 Feb; 614():16-23. PubMed ID: 26742637
[TBL] [Abstract][Full Text] [Related]
19. Neurotoxic regimens of methamphetamine induce persistent expression of phospho-c-Jun in somatosensory cortex and substantia nigra.
O'Dell SJ; Marshall JF
Synapse; 2005 Mar; 55(3):137-47. PubMed ID: 15549691
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis is secondary to non-apoptotic axonal degeneration in neurons exposed to Abeta in distal axons.
Song MS; Saavedra L; de Chaves EI
Neurobiol Aging; 2006 Sep; 27(9):1224-38. PubMed ID: 16122841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
